BridgeBio Pharma Inc. (BBIO) Announces Commercial Progress, Program Updates, and 2025 Milestones

Go back to BridgeBio Pharma Inc. (BBIO) Announces Commercial Progress, Program Updates, and 2025 Milestones
(NASDAQ: BBIO) Delayed: 79.89 +0.03 (0.04%)
Previous Close $79.86    52 Week High
Open $79.15    52 Week Low
Day High $80.42    P/E N/A 
Day Low $78.13    EPS
Volume 2,795,715